Lombard Odier Asset Management (Europe)’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,000	Closed	-$2.43M	–	163
2025 Q1	$2.43M	Hold	22,000	–	–	0.2%	115
2024 Q4	$3M	Buy	+22,000	New	+$3M	0.19%	136